Categories
Biocon Limited — Important, 29-04-2026: Updates
29-04-2026 · 07:48 pm
Biocon utilized 1800 Cr from Commercial Paper issuance to acquire subsidiary shares and 200 Cr for debenture transactions. All CP obligations have been fulfilled.
No comments yet. Be the first to comment!